N-Acetylcysteine Dosing
For acetaminophen overdose, administer N-acetylcysteine (NAC) intravenously at a total dose of 300 mg/kg over 21 hours using the FDA-approved three-bag regimen, ideally initiated within 8-10 hours of ingestion to prevent hepatotoxicity and mortality. 1
Acetaminophen Overdose Dosing
Standard IV Regimen (FDA-Approved Three-Bag Method)
The FDA-labeled regimen delivers 300 mg/kg total over 21 hours as three sequential infusions 1:
- Loading dose: 150 mg/kg IV over 1 hour (in 200 mL diluent)
- Second dose: 50 mg/kg IV over 4 hours (in 500 mL diluent)
- Third dose: 100 mg/kg IV over 16 hours (in 1000 mL diluent)
Critical timing: NAC must be diluted in sterile water, 0.45% sodium chloride, or 5% dextrose before administration because the undiluted solution is hyperosmolar (2600 mOsmol/L) 1.
When to Initiate Treatment
Administer NAC to patients at possible or probable risk for hepatotoxicity based on the Rumack-Matthew nomogram, ideally within 8-10 hours post-ingestion 2. Evidence demonstrates:
- Treatment within 8 hours: 0% severe hepatotoxicity
- Treatment 8-10 hours: minimal hepatotoxicity (one non-lethal case)
- Treatment 10-24 hours: 53% severe hepatotoxicity, 5% mortality 2
Do not administer NAC to patients below the nomogram line with no risk for hepatotoxicity 2.
Extended Therapy Considerations
In massive overdoses, co-ingestions, or pre-existing liver disease, continue NAC beyond 21 hours if 1:
- Acetaminophen levels remain detectable
- ALT/AST continue rising
- INR remains elevated
Contact poison control (1-800-222-1222) or the acetaminophen overdose assistance line (1-800-525-6115) for dosing guidance in these scenarios 1.
Alternative Regimens
Recent evidence supports a two-bag regimen (200 mg/kg over 4 hours, then 100 mg/kg over 16 hours) with similar efficacy but significantly fewer administration errors and adverse reactions 3, 4. A 2024 pediatric study found 4 errors with the two-bag versus 23 errors with the three-bag regimen (p<0.001), with equivalent hepatotoxicity rates 3. However, the FDA-approved three-bag regimen remains the standard in the United States 5.
The 12-hour SNAP protocol (300 mg/kg over 12 hours) is used internationally with comparable efficacy and reduced adverse effects, but is extended when stopping criteria aren't met 6.
Repeated Supratherapeutic Ingestion (RSI)
The Rumack-Matthew nomogram does not apply to RSI cases 1. RSI involves:
- ≥10 g or 200 mg/kg (whichever is less) in 24 hours, OR
- ≥6 g or 150 mg/kg (whichever is less) per 24 hours for ≥48 hours
Lower thresholds (4 g or 100 mg/kg) apply for high-risk patients (isoniazid use, prolonged fasting) 2.
Obtain acetaminophen levels, AST, ALT, bilirubin, INR, creatinine, BUN, glucose, and electrolytes to guide treatment. Contact poison control for specific RSI dosing recommendations 1.
Mucolytic Therapy
Respiratory Conditions
The evidence is insufficient to recommend for or against chronic NAC use as a mucolytic in cystic fibrosis patients ≥6 years 7. Studies showed no clinical benefit or lung function improvement, with poor quality evidence 7.
For pediatric respiratory diseases, oral NAC dosing 8:
- Acute conditions: 20 mg/kg/day
- Chronic conditions: 200 mg three times daily (primarily studied in children >9 years)
Weight-based dosing is recommended for children 2-9 years due to significant weight variations in this age group 8.
Key Safety Considerations
Hypersensitivity Reactions
Serious acute reactions (rash, hypotension, wheezing, bronchospasm) can occur soon after infusion initiation 1. If severe hypersensitivity occurs, immediately stop the infusion and initiate appropriate treatment 1.
Use extreme caution in asthmatic patients—one asthmatic patient died from bronchospasm after IV NAC 1. Monitor asthmatics closely throughout therapy.
Acute flushing and erythema typically occur 30-60 minutes after starting infusion and often resolve spontaneously. For reactions beyond simple flushing, temporarily interrupt infusion and/or administer antihistamines 1.
Common Pitfalls
- Never administer undiluted NAC intravenously—it must be diluted to avoid hyperosmolar complications 1
- Weight-based dosing errors are common with the three-bag regimen; double-check calculations 3, 5
- Don't rely on reported ingestion quantity—it's often inaccurate. Use serum acetaminophen levels 1
- Monitor hepatic/renal function and electrolytes throughout treatment 1